A New Paradigm for Post Partum Depression

ThinkGen’s client faced ingrained habits upon postpartum depression (PPD) market entry. The newly launched PPD Brand demonstrated higher efficacy vs. SSRIs. This treatment is administered as in-patient infusion and a PPD diagnosis was required for access. ThinkGen’s goal with this research project was to:

• Identify the drivers and barriers to early adoption and understand how HCPs discuss the Brand with patients and families.

• Among prescribers, the goal was to understand use in specific patient types, and how time to access and patient response to therapy impacts Brand perceptions and future use

Fill out the form to read our case study

What We Value

uHaf8W.tif

Integrity & Passion

We care and it shows. Unwavering customer focus & commitment to excellence are intrinsic to ThinkGen.
stTQom.tif

Mutual Respect

We value empathy and active listening, and foster a collaborative environment that supports and celebrates the diverse voices of our employees.
BZICZL.tif

Intellectual Curiosity

We’re always willing to try new things and aren’t afraid to fail, because it takes perseverance to forge new paths.
5wPp0A.tif

Continuous Innovation

We challenge ourselves daily to rethink and reimagine solutions for the obstacles our clients face.
ThinkGen is a corporate sponsor of the Healthcare Businesswomen’s Association (HBA)
Copyright © Gen., LLC 2022. All Rights Reserved